Skip to content
RDL Network logo
P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial — Patrícia O. Guimarães (2023) | RDL Network